Neuraptive Therapeutics is developing a therapeutic product to improve the speed and quality of recovery from peripheral nerve injury.

Neuraptive Therapeutics is developing novel surgical products to address the peripheral nerve surgery market. The Company’s franchise product is a therapeutic for administration during surgery to improve outcomes for patients undergoing acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. In addition, the Company is developing a suite of advanced microsurgical instruments for use in peripheral nerve surgery.

Industry: Health
Status: Active

Contact Information

http://neuraptive.com/

David Jackson PhD

CEO, Director, Founder

Stefan Proniuk PhD MBA

CDO

Evan Tzanis

EVP R&D

Vicki Abbas BSN RN

VP ClinOps